The anti-MRSA compound 3-O-alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 210, 103539
Abstract
No abstract availableKeywords
Funding Information
- Abney Foundation
- National Institutes of Health
This publication has 48 references indexed in Scilit:
- Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methodsNucleic Acids Research, 2013
- Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovaniPLOS ONE, 2011
- Considerations when prescribing trimethoprim-sulfamethoxazoleCanadian Medical Association Journal, 2011
- Proteomic Signature of Fatty Acid Biosynthesis Inhibition Available for In Vivo Mechanism-of-Action StudiesAntimicrobial Agents and Chemotherapy, 2011
- Proteome Analyses of Cellular Proteins in Methicillin-Resistant Staphylococcus aureus Treated with Rhodomyrtone, a Novel Antibiotic CandidatePLOS ONE, 2011
- Inducible Clindamycin Resistance in Staphylococcus aureus Isolated from Clinical SamplesJournal of Laboratory Physicians, 2011
- Looking toward basic science for potential drug discovery targets against community‐associated MRSAMedicinal Research Reviews, 2009
- Natural products in drug discoveryDrug Discovery Today, 2008
- Benefits of using multiple first-line therapies against malariaProceedings of the National Academy of Sciences, 2008
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003